Coronavirus Test Kits Market to Decline by USD 6.8 Billion from 2024-2028, but AI Adoption Is Transforming the Landscape - Technavio Report
| TMO Stock | USD 529.95 0.32 0.06% |
About 61% of Thermo Fisher's investor base is looking to short. The analysis of overall sentiment of trading Thermo Fisher Scientific stock suggests that many investors are alarmed at this time. Thermo Fisher's investing sentiment overview a quick insight into current market opportunities from investing in Thermo Fisher Scientific. Many technical investors use Thermo Fisher Scientific stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Thermo |
Report with market evolution powered by AI- The global coronavirus test kits market size is estimated to grow by USD -6.8 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of -72.6 percent during the forecast period. Rising adoption of rapid coronavirus test kits is driving market growth, with a trend towards increasing demand for point-of-care diagnostics. However, poor healthcare settings in developing countries poses a challenge. Key market players include Abb
Read at finance.yahoo.com
 |
Thermo Fisher Fundamental Analysis
We analyze Thermo Fisher's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Thermo Fisher using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Thermo Fisher based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Thermo Fisher is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Thermo Fisher Scientific Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Thermo Fisher stock to make a market-neutral strategy. Peer analysis of Thermo Fisher could also be used in its relative valuation, which is a method of valuing Thermo Fisher by comparing valuation metrics with similar companies.
Peers
Thermo Fisher Related Equities
| IDXX | IDEXX Laboratories | 2.14 | ||||
| A | Agilent Technologies | 1.17 | ||||
| CRL | Charles River | 1.10 | ||||
| ILMN | Illumina | 0.69 | ||||
| DHR | Danaher | 0.67 | ||||
| WAT | Waters | 0.62 | ||||
| MTD | Mettler Toledo | 0.61 | ||||
| RVTY | Revvity | 0.48 | ||||
| GH | Guardant Health | 0.25 |
Check out Thermo Fisher Hype Analysis, Thermo Fisher Correlation and Thermo Fisher Performance. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.